SCHEDULE 13G/A: Phillip Frost and Affiliates Maintain Significant Stake in Douglas Elliman Inc., Filing Amended Beneficial Ownership

Sentiment:

Beneficial Ownership Statement


Phillip Frost, M.D., Frost Gamma Investments Trust, and Patricia Frost have filed an amended Schedule 13G, disclosing their continued beneficial ownership of 8.6% of Douglas Elliman Inc.'s common stock as of January 1, 2025.

Summary

  • Phillip Frost, M.D., Frost Gamma Investments Trust, and Patricia Frost (collectively, the 'Reporting Persons') have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Douglas Elliman Inc.
  • As of January 1, 2025, the Reporting Persons collectively beneficially own 7,650,618 shares of Douglas Elliman Inc. Common Stock.
  • This aggregate ownership represents 8.6% of the total 89,166,991 shares of Common Stock outstanding, based on the Issuer's Form 10-Q for the quarter ending September 30, 2024.
  • Phillip Frost, M.D. has shared voting and dispositive power over 7,650,618 shares, which includes 7,641,642 shares held by Frost Gamma Investments Trust and 8,976 shares held by Patricia Frost.
  • Dr. Frost disclaims beneficial ownership of the 8,976 shares held by his spouse, Patricia Frost.
  • Frost Gamma Investments Trust holds 7,641,642 shares, representing 8.6% of the class, with shared voting and dispositive power.
  • Patricia Frost holds 8,976 shares, representing less than 0.1% of the class, with shared voting and dispositive power.

Sentiment

Score: 5

Explanation: Neutral. The document is a factual disclosure of beneficial ownership and does not contain qualitative statements about the company's performance or prospects.

Positives

  • Continued significant beneficial ownership by a prominent investor group, indicating a sustained interest in the company.

Negatives

  • The filing itself does not present any explicit negative information regarding the company's operations or financial health.

Risks

  • The document, being a beneficial ownership filing, does not detail specific risks related to Douglas Elliman Inc.'s operations or financial performance.

Future Outlook

NA

Industry Context

This filing reflects a significant ownership stake in Douglas Elliman Inc., a prominent real estate brokerage firm. The continued holding by a major investor group suggests a sustained interest in the real estate sector, though the filing itself does not provide specific industry analysis.

Stakeholder Impact

  • Shareholders: Provides transparency regarding significant ownership stakes, which can influence market perception and trading activity.

Key Dates

DateDescription
09/30/2024End of quarter for Douglas Elliman Inc.'s Quarterly Report on Form 10-Q, which reported 89,166,991 shares outstanding.
11/12/2024Date Douglas Elliman Inc. filed its Quarterly Report on Form 10-Q for the quarter ending September 30, 2024, with the SEC.
01/01/2025Date of event which required the filing of this Schedule 13G amendment.
02/11/2025Date the Schedule 13G Amendment No. 2 was signed and filed by the Reporting Persons.

Keywords

Douglas Elliman Inc., Common Stock, Schedule 13G, Beneficial Ownership, Phillip Frost, Frost Gamma Investments Trust, Patricia Frost, Real Estate, Investment, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.